These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8566940

  • 1. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication.
    Walker GA, Mac Hannaford JC.
    Fundam Clin Pharmacol; 1995; 9(4):387-94. PubMed ID: 8566940
    [Abstract] [Full Text] [Related]

  • 2. Buflomedil for intermittent claudication.
    De Backer TL, Vander Stichele RH, Bogaert MG.
    Cochrane Database Syst Rev; 2001; (1):CD000988. PubMed ID: 11279700
    [Abstract] [Full Text] [Related]

  • 3. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2007 Oct 17; (4):CD000988. PubMed ID: 17943749
    [Abstract] [Full Text] [Related]

  • 4. Buflomedil for intermittent claudication.
    de Backer TL, Bogaert M, Vander Stichele R.
    Cochrane Database Syst Rev; 2008 Jan 23; (1):CD000988. PubMed ID: 18253982
    [Abstract] [Full Text] [Related]

  • 5. Buflomedil for intermittent claudication.
    de Backer TL, Vander Stichele R.
    Cochrane Database Syst Rev; 2013 Mar 28; 2013(3):CD000988. PubMed ID: 23543509
    [Abstract] [Full Text] [Related]

  • 6. Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.
    Diamantopoulos EJ, Grigoriadou M, Ifanti G, Raptis SA.
    Int Angiol; 2001 Dec 28; 20(4):337-44. PubMed ID: 11782701
    [Abstract] [Full Text] [Related]

  • 7. A new pharmacological treatment for intermittent claudication: results of a randomized, multicenter trial.
    Beebe HG, Dawson DL, Cutler BS, Herd JA, Strandness DE, Bortey EB, Forbes WP.
    Arch Intern Med; 1999 Sep 27; 159(17):2041-50. PubMed ID: 10510990
    [Abstract] [Full Text] [Related]

  • 8. Buflomedil in arterial occlusive disease: results of a controlled multicenter study.
    Trübestein G, Balzer K, Bisler H, Klüken N, Muller-Wiefel H, Unkel B, Mahfoud Y, Ziegler W.
    Angiology; 1984 Aug 27; 35(8):500-5. PubMed ID: 6383127
    [Abstract] [Full Text] [Related]

  • 9. A placebo-controlled study of the effects of intravenous Buflomedil on foot skin microcirculation in patients with severe intermittent claudication.
    Van den Brande P, Maurel A.
    Angiology; 1998 Feb 27; 49(2):105-14. PubMed ID: 9482510
    [Abstract] [Full Text] [Related]

  • 10. Pentoxifylline for intermittent claudication.
    Salhiyyah K, Forster R, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
    Cochrane Database Syst Rev; 2015 Sep 29; 9(9):CD005262. PubMed ID: 26417854
    [Abstract] [Full Text] [Related]

  • 11. Double-blind placebo-controlled trial of buflomedil in intermittent claudication.
    Fonseca V, Mikhailidis DP, Barradas MA, Jeremy JY, Gracey L, Dandona P.
    Int J Clin Pharmacol Res; 1988 Sep 29; 8(5):377-81. PubMed ID: 3229875
    [Abstract] [Full Text] [Related]

  • 12. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 13. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H, Kieser M, Hölscher U.
    Vasa; 1998 May 12; 27(2):106-10. PubMed ID: 9612115
    [Abstract] [Full Text] [Related]

  • 14. A review of long-term safety data with buflomedil.
    Bachand RT, Dubourg AY.
    J Int Med Res; 1990 May 12; 18(3):245-52. PubMed ID: 2193838
    [Abstract] [Full Text] [Related]

  • 15. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease.
    Money SR, Herd JA, Isaacsohn JL, Davidson M, Cutler B, Heckman J, Forbes WP.
    J Vasc Surg; 1998 Feb 12; 27(2):267-74; discussion 274-5. PubMed ID: 9510281
    [Abstract] [Full Text] [Related]

  • 16. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial.
    Dawson DL, Cutler BS, Meissner MH, Strandness DE.
    Circulation; 1998 Aug 18; 98(7):678-86. PubMed ID: 9715861
    [Abstract] [Full Text] [Related]

  • 17. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
    Chacón-Quevedo A, Eguaras MG, Calleja F, Garcia MA, Roman M, Casares J, Muñoz I, Concha M.
    Angiology; 1994 Jul 18; 45(7):647-53. PubMed ID: 8024164
    [Abstract] [Full Text] [Related]

  • 18. Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies.
    Momsen AH, Jensen MB, Norager CB, Madsen MR, Vestersgaard-Andersen T, Lindholt JS.
    Eur J Vasc Endovasc Surg; 2009 Oct 18; 38(4):463-74. PubMed ID: 19586783
    [Abstract] [Full Text] [Related]

  • 19. Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.
    Gresele P, Migliacci R, Di Sante G, Nenci GG, CRAMPS Investigator Group.
    Vasc Med; 2000 Oct 18; 5(2):83-9. PubMed ID: 10943584
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of the effectiveness of intra-arterial and intravenous administration of buflomedil in patients with intermittent claudication].
    Diehm C, Eckstein M, Hübsch-Müller C.
    Vasa; 1989 Oct 18; 18(1):40-7. PubMed ID: 2648691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.